119 related articles for article (PubMed ID: 8937391)
1. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients.
Perkins NL; Coughlan EP; Franklin RA; Reid MR; Taylor J
N Z Med J; 1996 Oct; 109(1032):402-5. PubMed ID: 8937391
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
Suligoi B; Calistri A; Cusini M; Palù G;
J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
[TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City].
Conde-González CJ; Lazcano-Ponce E; Hernández-Girón C; Juárez-Figueroa L; Smith JS; Hernández-Avila M
Salud Publica Mex; 2003; 45 Supp 5():S608-16. PubMed ID: 14974271
[TBL] [Abstract][Full Text] [Related]
4. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
Jonsson MK; Levi M; Rudén U; Wahren B
Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
[TBL] [Abstract][Full Text] [Related]
5. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.
Slomka MJ
Commun Dis Rep CDR Rev; 1996 Mar; 6(3):R41-5. PubMed ID: 8820192
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of herpes simplex virus type 2 in adult HIV-infected patients and blood donors in Croatia.
Rode OD; Lepej SZ; Begovac J
Coll Antropol; 2008 Sep; 32(3):693-5. PubMed ID: 18982739
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States.
Xu F; Markowitz LE; Gottlieb SL; Berman SM
Am J Obstet Gynecol; 2007 Jan; 196(1):43.e1-6. PubMed ID: 17240228
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel.
Feldman PA; Steinberg J; Madeb R; Bar G; Nativ O; Tal J; Srugo I
Isr Med Assoc J; 2003 Sep; 5(9):626-8. PubMed ID: 14509150
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons.
Ramaswamy M; Sabin C; McDonald C; Smith M; Taylor C; Geretti AM
Sex Transm Dis; 2006 Feb; 33(2):96-101. PubMed ID: 16432480
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris.
Janier M; Lassau F; Bloch J; Spindler E; Morel P; Gérard P; Aufrère A
Int J STD AIDS; 1999 Aug; 10(8):522-6. PubMed ID: 10471101
[TBL] [Abstract][Full Text] [Related]
11. Herpes simplex virus type 2 (HSV-2) infection in women attending an antenatal clinic in the South Pacific island nation of Vanuatu.
Haddow LJ; Sullivan EA; Taylor J; Abel M; Cunningham AL; Tabrizi S; Mindel A
Sex Transm Dis; 2007 May; 34(5):258-61. PubMed ID: 16940899
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
Ross SE; Carter B; Lambert S
Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
[TBL] [Abstract][Full Text] [Related]
13. Low seroprevalence of herpes simplex virus type 2 among pregnant women in Senegal.
Diawara S; Toure Kane C; Legoff J; Gaye AG; Mboup S; Bélec L
Int J STD AIDS; 2008 Mar; 19(3):159-60. PubMed ID: 18397553
[TBL] [Abstract][Full Text] [Related]
14. Type-specific seroprevalence of herpes simplex virus type 2 and associated risk factors in middle-aged women from 6 countries: the IARC multicentric study.
Patnaik P; Herrero R; Morrow RA; Munoz N; Bosch FX; Bayo S; El Gueddari B; Caceres E; Chichareon SB; Castellsague X; Meijer CJ; Snijders PJ; Smith JS
Sex Transm Dis; 2007 Dec; 34(12):1019-24. PubMed ID: 18080353
[TBL] [Abstract][Full Text] [Related]
15. Population-based prevalence of antibodies against herpes simplex virus type 2 and socio-demographic characteristics in Mexico.
Uribe-Salas F; Palma-Coca O; Sánchez-Alemán MA; Olamendi M; Juárez-Figueroa L; Conde-Glez CJ
Trans R Soc Trop Med Hyg; 2009 Feb; 103(2):151-8. PubMed ID: 19084884
[TBL] [Abstract][Full Text] [Related]
16. The burden of infection with herpes simplex virus type 1 and type 2: seroprevalence study in Estonia.
Uusküla A; Nygard-Kibur M; Cowan FM; Mayaud P; French RS; Robinson JN; Brown DW
Scand J Infect Dis; 2004; 36(10):727-32. PubMed ID: 15513398
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics.
Gottlieb SL; Douglas JM; Schmid DS; Bolan G; Iatesta M; Malotte CK; Zenilman J; Foster M; Barón AE; Steiner JF; Peterman TA; Kamb ML;
J Infect Dis; 2002 Nov; 186(10):1381-9. PubMed ID: 12404152
[TBL] [Abstract][Full Text] [Related]
18. Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002.
Davidovici BB; Grotto I; Balicer RD; Robinson NJ; Cohen D
Sex Transm Dis; 2006 Nov; 33(11):641-5. PubMed ID: 16614586
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004.
Schillinger JA; McKinney CM; Garg R; Gwynn RC; White K; Lee F; Blank S; Thorpe L; Frieden T
Sex Transm Dis; 2008 Jun; 35(6):599-606. PubMed ID: 18418295
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of HSV-2 antibody in a Melbourne antenatal population attending a tertiary obstetric hospital.
Sasadeusz JJ; Silvers JE; Kent HE; Devenish W; Hocking J; Garland SM
Aust N Z J Obstet Gynaecol; 2008 Jun; 48(3):266-72. PubMed ID: 18532957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
